| Year |
Citation |
Score |
| 2014 |
Ammad-ud-din M, Georgii E, Gönen M, Laitinen T, Kallioniemi O, Wennerberg K, Poso A, Kaski S. Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization. Journal of Chemical Information and Modeling. 54: 2347-2359. PMID 25046554 DOI: 10.1021/Ci500152B |
0.345 |
|
| 2010 |
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, ... ... Kallioniemi OP, et al. International network of cancer genome projects. Nature. 464: 993-8. PMID 20393554 DOI: 10.1038/Nature08987 |
0.319 |
|
| 2009 |
Autio R, Kilpinen S, Saarela M, Kallioniemi O, Hautaniemi S, Astola J. Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations Bmc Bioinformatics. 10: 1-12. PMID 19208124 DOI: 10.1186/1471-2105-10-S1-S24 |
0.314 |
|
| 2005 |
Lugli A, Spichtin H, Maurer R, Mirlacher M, Kiefer J, Huusko P, Azorsa D, Terracciano L, Sauter G, Kallioniemi OP, Mousses S, Tornillo L. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6450-8. PMID 16166419 DOI: 10.1158/1078-0432.Ccr-04-2458 |
0.346 |
|
| 2005 |
Rökman A, Baffoe-Bonnie AB, Gillanders E, Fredriksson H, Autio V, Ikonen T, Gibbs KD, Jones M, Gildea D, Freas-Lutz D, Markey C, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, et al. Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Human Genetics. 116: 43-50. PMID 15549392 DOI: 10.1007/S00439-004-1214-7 |
0.34 |
|
| 2004 |
Syrjäkoski K, Kuukasjärvi T, Waltering K, Haraldsson K, Auvinen A, Borg A, Kainu T, Kallioniemi OP, Koivisto PA. BRCA2 mutations in 154 finnish male breast cancer patients. Neoplasia (New York, N.Y.). 6: 541-5. PMID 15548363 DOI: 10.1593/Neo.04193 |
0.342 |
|
| 2004 |
Järvinen AK, Hautaniemi S, Edgren H, Auvinen P, Saarela J, Kallioniemi OP, Monni O. Are data from different gene expression microarray platforms comparable? Genomics. 83: 1164-8. PMID 15177569 DOI: 10.1016/J.Ygeno.2004.01.004 |
0.365 |
|
| 2004 |
Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M, Elkahloun A, Monni O, Chen Y, Kallioniemi A, Kallioniemi OP. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia (New York, N.Y.). 6: 240-7. PMID 15153336 DOI: 10.1593/neo.3439 |
0.483 |
|
| 2004 |
Srivastava M, Bubendorf L, Raffeld M, Bucher C, Torhorst J, Sauter G, Olsen C, Kallioniemi OP, Eidelman O, Pollard HB. Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2344-50. PMID 15073110 |
0.4 |
|
| 2004 |
Syrjäkoski K, Kuukasjärvi T, Auvinen A, Kallioniemi OP. CHEK2 1100delC is not a risk factor for male breast cancer population. International Journal of Cancer. 108: 475-6. PMID 14648717 DOI: 10.1002/Ijc.11384 |
0.391 |
|
| 2004 |
Huusko P, Juo SH, Gillanders E, Sarantaus L, Kainu T, Vahteristo P, Allinen M, Jones M, Rapakko K, Eerola H, Markey C, Vehmanen P, Gildea D, Freas-Lutz D, Blomqvist C, ... ... Kallioniemi OP, et al. Genome-wide scanning for linkage in Finnish breast cancer families. European Journal of Human Genetics : Ejhg. 12: 98-104. PMID 14560309 DOI: 10.1038/Sj.Ejhg.5201091 |
0.507 |
|
| 2004 |
Huusko P, Juo SH, Gillanders E, Sarantaus L, Kainu T, Vahteristo P, Allinen M, Jones M, Rapakko K, Eerola H, Markey C, Vehmanen P, Gildea D, Freas-Lutz D, Blomqvist C, ... ... Kallioniemi O, et al. Erratum: Genome-wide scanning for linkage in Finnish breast cancer families European Journal of Human Genetics. 12: 256-256. DOI: 10.1038/Sj.Ejhg.5201140 |
0.425 |
|
| 2003 |
Schleutker J, Baffoe-Bonnie AB, Gillanders E, Kainu T, Jones MP, Freas-Lutz D, Markey C, Gildea D, Riedesel E, Albertus J, Gibbs KD, Matikainen M, Koivisto PA, Tammela T, Bailey-Wilson JE, ... ... Kallioniemi OP, et al. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. The Prostate. 57: 280-9. PMID 14601024 DOI: 10.1002/Pros.10302 |
0.329 |
|
| 2003 |
Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, Lehtimäki T, Salonen JT. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. Journal of the National Cancer Institute. 95: 812-8. PMID 12783936 DOI: 10.1093/Jnci/95.11.812 |
0.329 |
|
| 2003 |
Syrjäkoski K, Hyytinen ER, Kuukasjärvi T, Auvinen A, Kallioniemi OP, Kainu T, Koivisto PA. Androgen receptor gene alterations in Finnish male breast cancer. Breast Cancer Research and Treatment. 77: 167-70. PMID 12602915 DOI: 10.1023/A:1021369508561 |
0.37 |
|
| 2003 |
Hautaniemi S, Yli-Harja O, Astola J, Kauraniemi P, Kallioniemi A, Wolf M, Ruiz J, Mousses S, Kallioniemi O. Analysis and Visualization of Gene Expression Microarray Data in Human Cancer Using Self-Organizing Maps Machine Learning. 52: 45-66. DOI: 10.1023/A:1023941307670 |
0.367 |
|
| 2002 |
Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringnér M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Research. 62: 6240-5. PMID 12414653 |
0.412 |
|
| 2002 |
Bärlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes, Chromosomes & Cancer. 35: 311-7. PMID 12378525 DOI: 10.1002/Gcc.10121 |
0.564 |
|
| 2002 |
Mononen N, Ikonen T, Autio V, Rökman A, Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J. Androgen receptor CAG polymorphism and prostate cancer risk. Human Genetics. 111: 166-71. PMID 12189490 DOI: 10.1007/S00439-002-0776-5 |
0.313 |
|
| 2002 |
Vahteristo P, Bartkova J, Eerola H, Syrjäkoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomäki K, Heikkilä P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. American Journal of Human Genetics. 71: 432-8. PMID 12094328 DOI: 10.1086/341943 |
0.42 |
|
| 2002 |
Skotheim RI, Monni O, Mousses S, Fosså SD, Kallioniemi OP, Lothe RA, Kallioniemi A. New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Research. 62: 2359-64. PMID 11956097 |
0.353 |
|
| 2002 |
Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson JT, Syrjakoski K, Weaver D, Haraldsson K, Johannsdottir HK, Vehmanen P, Nigam S, Golberger N, Robbins C, Pak E, Dutra A, Gillander E, ... ... Kallioniemi OP, et al. A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes. Human Genetics. 110: 111-21. PMID 11935316 DOI: 10.1007/S00439-001-0646-6 |
0.485 |
|
| 2002 |
Krajewska M, Zapata JM, Meinhold-Heerlein I, Hedayat H, Monks A, Bettendorf H, Shabaik A, Bubendorf L, Kallioniemi OP, Kim H, Reifenberger G, Reed JC, Krajewski S. Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia (New York, N.Y.). 4: 129-40. PMID 11896568 DOI: 10.1038/Sj.Neo.7900222 |
0.383 |
|
| 2002 |
Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Research. 62: 1256-60. PMID 11888886 |
0.312 |
|
| 2002 |
Mousses S, Kallioniemi A, Kauraniemi P, Elkahloun A, Kallioniemi OP. Clinical and functional target validation using tissue and cell microarrays. Current Opinion in Chemical Biology. 6: 97-101. PMID 11827831 DOI: 10.1016/S1367-5931(01)00283-6 |
0.308 |
|
| 2002 |
Matikainen M, Schleutker J, Gillanders E, Baffoe-Bonnie A, Jones MP, Kainu T, Markey C, Koivisto P, Tammela T, Bailey-Wilson J, Trent J, Kallioniemi O. Novel region of interest in chromosome 11 and other putative regions identified in a genome-wide scan in finnish hereditary prostate cancer families European Urology Supplements. 1: 8. DOI: 10.1016/S1569-9056(02)80020-3 |
0.451 |
|
| 2001 |
Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Köchli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. The American Journal of Pathology. 159: 2249-56. PMID 11733374 DOI: 10.1016/S0002-9440(10)63075-1 |
0.415 |
|
| 2001 |
Nocito A, Kononen J, Kallioniemi O, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. International Journal of Cancer. 94: 1-5. PMID 11668471 DOI: 10.1002/Ijc.1385 |
0.387 |
|
| 2001 |
Monni O, Hyman E, Mousses S, Barlund M, Kallioniemi A, Kallioniemi O. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome. Seminars in Cancer Biology. 11: 395-401. PMID 11562182 DOI: 10.1006/Scbi.2001.0395 |
0.554 |
|
| 2001 |
Kallioniemi O. Biochip technologies in cancer research. Annals of Medicine. 33: 142-147. PMID 11327117 DOI: 10.3109/07853890109002069 |
0.404 |
|
| 2001 |
Kallioniemi O, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer Human Molecular Genetics. 10: 657-662. PMID 11257096 DOI: 10.1093/Hmg/10.7.657 |
0.405 |
|
| 2001 |
Rökman A, Koivisto PA, Matikainen MP, Kuukasjärvi T, Poutiainen M, Helin HJ, Karhu R, Kallioniemi O, Schleutker J. Genetic changes in familial prostate cancer by comparative genomic hybridization. The Prostate. 46: 233-239. PMID 11170152 DOI: 10.1002/1097-0045(20010215)46:3<233::Aid-Pros1028>3.0.Co;2-W |
0.468 |
|
| 2001 |
Vahteristo P, Syrjäkoski K, Eerola H, Kainu T, Holli K, Blomqvist C, Kallioniemi O, Nevanlinna H. Response: Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients Journal of the National Cancer Institute. 93: 153-154. DOI: 10.1093/Jnci/93.2.153 |
0.36 |
|
| 2000 |
Desper R, Jiang F, Kallioniemi O, Moch H, Papadimitriou CH, Schäffer AA. Distance-based reconstruction of tree models for oncogenesis. Journal of Computational Biology. 7: 789-803. PMID 11382362 DOI: 10.1089/10665270050514936 |
0.394 |
|
| 2000 |
Forozan F, Mahlamäki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A, Kallioniemi OP. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Research. 60: 4519-25. PMID 10969801 |
0.746 |
|
| 2000 |
Kainu T, Juo SHH, Desper R, Schäffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjäkoski K, Kuukasjärvi T, Koivisto P, et al. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus Proceedings of the National Academy of Sciences of the United States of America. 97: 9603-9608. PMID 10944226 DOI: 10.1073/Pnas.97.17.9603 |
0.545 |
|
| 2000 |
Bärlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, Kallioniemi A. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. Journal of the National Cancer Institute. 92: 1252-9. PMID 10922410 DOI: 10.1093/Jnci/92.15.1252 |
0.741 |
|
| 1999 |
Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioniemi A, Kallioniemi OP, Ethier SP. Molecular cytogenetic analysis of 11 new breast cancer cell lines. British Journal of Cancer. 81: 1328-34. PMID 10604729 DOI: 10.1038/sj.bjc.6695007 |
0.741 |
|
| 1999 |
Desper R, Jiang F, Kallioniemi O, Moch H, Papadimitriou CH, Schäffer AA. Inferring tree models for oncogenesis from comparative genome hybridization data. Journal of Computational Biology. 6: 37-51. PMID 10223663 DOI: 10.1089/Cmb.1999.6.37 |
0.452 |
|
| 1999 |
Tirkkonen M, Kainu T, Loman N, Jóhannsson ÓT, Olsson H, Barkardóttir RB, Kallioniemi O, Borg Å. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer Genes, Chromosomes and Cancer. 24: 56-61. PMID 9892109 DOI: 10.1002/(Sici)1098-2264(199901)24:1<56::Aid-Gcc8>3.0.Co;2-X |
0.518 |
|
| 1999 |
Mousses S, Bubendorf L, Kononen J, Kolmer M, Kallioniemi O, Koivisto P, Pretlow T, Elkahloun A, Sauter G, Gasser TC. Molecular Mechanisms Underlying Endocrine Therapy Failure In Human Prostate Cancer Analyzed By Dna And Tissue Microarrays The Journal of Urology. 123. DOI: 10.1097/00005392-199904010-00495 |
0.34 |
|
| 1999 |
Matikainen MP, Schleutker J, Koivisto PA, Tammela T, Xu J, Isaacs WB, Smith JR, Carpten JD, Stephan DA, Bailey-Wilson JE, Trent JM, Kallioniemi O. Genetic Epidemiology Of Hereditary Prostate Cancer In Finland: Discovery Of Novel Susceptibility Loci The Journal of Urology. 54. DOI: 10.1097/00005392-199904010-00220 |
0.342 |
|
| 1999 |
Bubendorf L, Kononen J, Kallioniemi O, Koivisto P, Gasser TC, Schraml P, Willi N, Sauter G. High-Throughput Survey Of Gene Amplifications Underlying Prostate Cancer Progression Using A Novel Tissue Microarray ("Tissue Chip") Technology The Journal of Urology. 51. DOI: 10.1097/00005392-199904010-00205 |
0.365 |
|
| 1998 |
Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi O. Molecular cytogenetics of primary breast cancer by CGH. Genes, Chromosomes and Cancer. 21: 177-184. PMID 9523192 DOI: 10.1002/(Sici)1098-2264(199803)21:3<177::Aid-Gcc1>3.0.Co;2-X |
0.602 |
|
| 1997 |
Mahlamäki EH, Höglund M, Gorunova L, Karhu R, Dawiskiba S, Andrén-Sandberg Å, Kallioniemi O, Johansson B. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes, Chromosomes and Cancer. 20: 383-391. PMID 9408755 DOI: 10.1002/(Sici)1098-2264(199712)20:4<383::Aid-Gcc10>3.0.Co;2-O |
0.528 |
|
| 1997 |
Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjäkoski K, Pyrhönen S, Kallioniemi OP, Muhonen T, Luce M, Frank TS, Nevanlinna H. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Human Molecular Genetics. 6: 2309-15. PMID 9361038 DOI: 10.1093/Hmg/6.13.2309 |
0.412 |
|
| 1997 |
Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. Genome screening by comparative genomic hybridization. Trends in Genetics : Tig. 13: 405-9. PMID 9351342 DOI: 10.1016/S0168-9525(97)01244-4 |
0.712 |
|
| 1997 |
Kallioniemi O. Linking chromosomal clues Nature Genetics. 15: 5-6. PMID 8988157 DOI: 10.1038/Ng0197-5 |
0.391 |
|
| 1996 |
Kallioniemi A, Visakorpi T, Karhu R, Pinkel D, Kallioniemi O. Gene Copy Number Analysis by Fluorescencein SituHybridization and Comparative Genomic Hybridization Methods. 9: 113-121. PMID 9245350 DOI: 10.1006/Meth.1996.0015 |
0.485 |
|
| 1996 |
Kallioniemi O, Visakorpi T. Genetic basis and clonal evolution of human prostate cancer. Advances in Cancer Research. 68: 225-255. PMID 8712069 DOI: 10.1016/S0065-230X(08)60355-3 |
0.349 |
|
| 1996 |
Koivisto P, Visakorpi T, Kallioniemi O. Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer. Scandinavian Journal of Clinical & Laboratory Investigation. 56: 57-63. DOI: 10.1080/00365519609168299 |
0.337 |
|
| 1996 |
Kallioniemi O. Comparative genomic hybridization gaining in popularity Trends in Genetics. 12: 237-238. DOI: 10.1016/0168-9525(96)81445-4 |
0.392 |
|
| 1995 |
Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genetics. 9: 401-406. PMID 7795646 DOI: 10.1038/Ng0495-401 |
0.391 |
|
| 1995 |
Kallioniemi A, Kallioniemi O, Citro G, Sauter G, Devries S, Kerschmann R, Caroll P, Waldman F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes, Chromosomes and Cancer. 12: 213-219. PMID 7536461 DOI: 10.1002/Gcc.2870120309 |
0.584 |
|
| 1994 |
Kallioniemi OP, Visakorpi T, Holli K, Isola JJ, Rabinovitch PS. Automated peak detection and cell cycle analysis of flow cytometric DNA histograms. Cytometry. 16: 250-5. PMID 7924694 DOI: 10.1002/Cyto.990160309 |
0.347 |
|
| 1994 |
Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi O, Isola JJ. Improved Technique For Analysis Of Formalin-Fixed, Paraffin-Embedded Tumors By Fluorescence In Situ Hybridization Cytometry. 16: 93-99. PMID 7924686 DOI: 10.1002/Cyto.990160202 |
0.403 |
|
| 1992 |
Isola J, Visakorpi T, Holli K, Kallioniemi O. Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients Journal of the National Cancer Institute. 84: 1109-1114. PMID 1352359 DOI: 10.1093/Jnci/84.14.1109 |
0.413 |
|
| 1992 |
Kallioniemi O, Kallioniemi A, Kurisu W, Thor A, Chen L, Smith HS, Waldman FM, Pinkel D, Gray JW. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proceedings of the National Academy of Sciences of the United States of America. 89: 5321-5325. PMID 1351679 DOI: 10.1073/Pnas.89.12.5321 |
0.487 |
|
| 1992 |
Visakorpi T, Kallioniemi O, Heikkinen A, Koivula T, Isola J. Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation Journal of the National Cancer Institute. 84: 883-887. PMID 1350643 DOI: 10.1093/Jnci/84.11.883 |
0.329 |
|
| 1991 |
Kallioniemi O, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. International Journal of Cancer. 49: 650-655. PMID 1682277 DOI: 10.1002/Ijc.2910490504 |
0.398 |
|
| 1990 |
Kallioniemi O, Joensuu H, Klemi P, Koivula T. Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinomas. Breast Cancer Research and Treatment. 17: 59-61. PMID 2095929 DOI: 10.1007/Bf01812686 |
0.339 |
|
| Show low-probability matches. |